<!doctype html public "-//IETF//DTD HTML//EN">
<HTML>
<HEAD>
<TITLE>Converted by EDGARwiz</TITLE>
<META NAME="date" CONTENT="07/25/2014">
</HEAD>
<BODY style="line-height:12pt; font-family:Times New Roman; font-size:10pt; color:#000000">
<DIV style="width:624px"><P style="line-height:0.75pt; margin-top:11.333px; margin-bottom:0px" align=center><BR></P>
<P style="margin-top:11.333px; margin-bottom:0px" align=center><BR></P>
<P style="margin:0px" align=center><B>UNITED STATES SECURITIES AND EXCHANGE COMMISSION</B></P>
<P style="margin:0px" align=center><B>Washington, D.C. 20549</B></P>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px" align=center><BR></P>
<P style="line-height:20pt; margin:0px; font-size:18pt" align=center><B>FORM 8-K</B></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px" align=center><B>CURRENT REPORT</B></P>
<P style="margin:0px" align=center><B>Pursuant to Section 13 or 15(d) of</B></P>
<P style="margin:0px" align=center><B>the Securities and Exchange Act of 1934</B></P>
<P style="margin:0px" align=center>&nbsp;</P>
<P style="margin:0px" align=center><B>PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</B></P>
<P style="margin:0px" align=center>&nbsp;</P>
<P style="margin:0px" align=center>Date of Report (Date of Nearest event reported): July 22, 2014</P>
<P style="margin:0px" align=center><BR>
&nbsp;</P>
<P style="margin:0px">&nbsp;</P>
<P style="margin:0px" align=center><B><U>BIOCUBE, INC.</U></B></P>
<P style="margin:0px" align=center>(Exact Name of Registrant as Specified in its Charter)</P>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px" align=center>&nbsp;</P>
<TABLE style="font-size:10pt" cellspacing=0><TR height=0 style="font-size:0"><TD width=186></TD><TD width=240></TD><TD width=198></TD></TR>
<TR><TD valign=top width=186><P style="margin:0px; padding-right:1.067px" align=center><U>Delaware&nbsp;</U></P>
</TD><TD valign=top width=240><P style="margin:0px; padding-right:1.067px" align=center><U>333-137920</U></P>
</TD><TD valign=top width=198><P style="margin:0px; padding-right:1.067px" align=center><U>20-3547389</U></P>
</TD></TR>
<TR><TD valign=top width=186><P style="margin:0px; padding-right:1.067px" align=center><B>(State of Organization)&nbsp;</B></P>
</TD><TD valign=top width=240><P style="margin:0px; padding-right:1.067px" align=center><B>(Commission File Number)&nbsp;</B></P>
</TD><TD valign=top width=198><P style="margin:0px; padding-right:1.067px" align=center><B>(I.R.S. Employer</B></P>
</TD></TR>
<TR><TD valign=top width=186><P style="margin:0px; padding-right:1.067px"><B>&nbsp;</B></P>
</TD><TD valign=top width=240><P style="margin:0px; padding-right:1.067px"><B>&nbsp;</B></P>
</TD><TD valign=top width=198><P style="margin:0px; padding-right:1.067px" align=center><B>Identification No.)</B></P>
</TD></TR>
</TABLE>
<P style="margin:0px">&nbsp;</P>
<P style="margin:0px" align=center>10 BLACKLEDGE COURT, CLOSTER NJ 07624</P>
<P style="line-height:14pt; margin:0px; font-size:12pt" align=center><B><U>________________________________________________</U></B></P>
<P style="margin:0px" align=center>(Address of principal executive offices)</P>
<P style="margin:0px">&nbsp;</P>
<P style="margin:0px" align=center>Registrant&#146;s telephone number, including area code: &nbsp;(201)750-2001 </P>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px; padding-left:6px">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</P>
<P style="margin:0px; padding-left:6px">&nbsp;</P>
<P style="margin:0px; padding-left:6px; font-family:Wingdings">&#168;<FONT style="font-family:Times New Roman"> Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</FONT></P>
<P style="margin:0px; padding-left:6px">&nbsp;</P>
<P style="margin:0px; padding-left:6px; font-family:Wingdings">&#168;<FONT style="font-family:Times New Roman"> Soliciting material pursuant to Rule 14a-12 under the Merger Act (17 CFR 240.14a -12)</FONT></P>
<P style="margin:0px; padding-left:6px">&nbsp;</P>
<P style="margin:0px; padding-left:6px; font-family:Wingdings">&#168;<FONT style="font-family:Times New Roman"> Pre-commencement communications pursuant to Rule 14d-2(b) under the Merger Act (17 CFR 240.14d -2(b))</FONT></P>
<P style="margin:0px; padding-left:6px">&nbsp;</P>
<P style="margin:0px; padding-left:6px; font-family:Wingdings">&#168;<FONT style="font-family:Times New Roman"> Pre-commencement communications pursuant to Rule 13e-4(c) under the Merger Act (17 CFR 240.13e -4(c))</FONT></P>
<P style="margin:0px" align=center><BR>
<BR></P>
<P style="margin:0px; page-break-before:always" align=center><BR></P>
<P style="line-height:13pt; margin:0px; font-size:11pt"><B>ITEM 4.01. &nbsp;CHANGES IN REGISTRANT&#8217;S CERTIFYING ACCOUNTANT.</B></P>
<P style="margin:0px"><BR></P>
<P style="line-height:13pt; margin:0px; font-size:11pt" align=justify><I>(a) Dismissal of Independent Registered Public Accounting Firm</I></P>
<P style="margin:0px" align=justify><BR></P>
<P style="line-height:13pt; margin:0px; font-size:11pt" align=justify>On July 22, 2014, Moss, Krusick &amp; Associates, LLC (&#147;<U>Moss</U>&#148;) was dismissed as the independent registered public accounting firm of BioCube, Inc. (the &#147;<U>Company</U>&#148;). &nbsp;The Company&#146;s Board of Directors, acting in the capacity of an audit committee, approved the dismissal of Moss.</P>
<P style="margin:0px"><BR></P>
<P style="line-height:13pt; margin:0px; font-size:11pt" align=justify>Moss&#146;s reports on the Company&#146;s financial statements for the years ended January 31, 2013 and 2012, respectively, did not contain any adverse opinion or disclaimer of opinion, nor were they qualified or modified as to uncertainty, audit scope or accounting p<A NAME="_GoBack"></A>rinciples except that the reports for both years indicated that the Company is in the development stage and has suffered operating losses. &nbsp;Accordingly, such reports indicated that there was substantial doubt as to the Company&#146;s ability to continue as a going concern and that the financial statements did not include any adjustments that might result from the outcome of this uncertainty.</P>
<P style="margin:0px"><BR></P>
<P style="line-height:13pt; margin:0px; font-size:11pt" align=justify>During the years ended January 31, 2013 and 2012, and through July 22, 2014, there were no disagreements with Moss on any matter of accounting principles or practices, financial statement disclosure or auditing scope or procedure, which disagreements, if not resolved to the satisfaction of Moss, would have caused it to make reference thereto in connection with its reports on the financial statements for such years. &nbsp;During the years ended January 31, 2013 and 2012, and through July 22, 2014, there were no matters that were either the subject of a disagreement as defined in Item 304(a)(1)(iv) of Regulation S-K or a reportable event as described in Item 304(a)(1)(v) of Regulation S-K.</P>
<P style="margin:0px"><BR></P>
<P style="line-height:13pt; margin:0px; font-size:11pt" align=justify>The Company provided Moss with a copy of the foregoing disclosures and requested Moss to furnish the Company with a letter addressed to the Securities and Exchange Commission stating whether or not Moss agrees with the disclosures. &nbsp;A copy of Moss&#146;s letter is filed as Exhibit 16.1 to this Current Report on Form 8-K.</P>
<P style="margin:0px"><BR></P>
<P style="line-height:13pt; margin:0px; font-size:11pt"><I>(b) New Independent Registered Public Accounting Firm</I></P>
<P style="margin:0px"><BR></P>
<P style="line-height:13pt; margin:0px; font-size:11pt" align=justify>On July 23, 2014, the Company&#146;s Board of Directors, acting in the capacity of an audit committee, engaged Li and Company, PC (&#147;Li&#148;) as the Company&#146;s new independent registered public accounting firm to act as the principal accountant to audit the Company&#146;s financial statements. &nbsp;During the Company&#146;s fiscal years ended January 31, 2013 and 2012, and through July 23, 2014, neither the Company, nor anyone acting on its behalf, consulted with Li regarding the application of accounting principles to a specific completed or proposed transaction or the type of audit opinion that might be rendered on the Company&#146;s financial statements, and no written report or oral advice was provided that Li concluded was an important factor considered by the Company in reaching a decision as to any such accounting, auditing or financial reporting issue.</P>
<P style="margin:0px"><BR></P>
<P style="line-height:13pt; margin:0px; font-size:11pt"><B>Item 9.01. &nbsp;Financial Statements and Exhibits.</B></P>
<P style="margin:0px"><BR></P>
<TABLE style="font-size:10pt" cellspacing=0><TR height=0 style="font-size:0"><TD width=85.2></TD><TD width=18></TD><TD width=535.2></TD></TR>
<TR><TD style="border-bottom:1px solid #000000" valign=top width=85.2><P style="line-height:13pt; margin:0px; font-size:11pt" align=center><B>Exhibit No.</B></P>
</TD><TD valign=top width=18><P>&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" valign=top width=535.2><P style="line-height:13pt; margin:0px; font-size:11pt"><B>Description</B></P>
</TD></TR>
<TR><TD valign=top width=85.2><P>&nbsp;</P></TD><TD valign=top width=18><P>&nbsp;</P></TD><TD valign=top width=535.2><P>&nbsp;</P></TD></TR>
<TR><TD valign=top width=85.2><P style="line-height:13pt; margin:0px; font-size:11pt; color:#FFFF00" align=center><A HREF="exhibit20161.htm"><U>16.1</U></A><FONT style="color:#000000"></FONT></P>
</TD><TD valign=top width=18><P>&nbsp;</P></TD><TD valign=top width=535.2><P style="line-height:13pt; margin:0px; font-size:11pt" align=justify>Letter to the Securities and Exchange Commission from Moss, Krusick &amp; Associates, LLC regarding the matters disclosed in Item 4.01 of this Current Report on Form 8-K.</P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px" align=center><BR>
<BR></P>
<P style="line-height:13pt; margin:0px; text-indent:310.333px; font-family:Calibri; font-size:11pt">2</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<P style="line-height:13pt; margin:0px; font-size:11pt; page-break-before:always" align=center><B>SIGNATURES</B></P>
<P style="margin:0px; font-size:11pt">&nbsp;</P>
<P style="line-height:13pt; margin:0px; text-indent:61.067px; font-size:11pt">Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>
<P style="margin:0px; font-size:11pt">&nbsp;</P>
<TABLE style="font-size:10pt" cellspacing=0><TR height=0 style="font-size:0"><TD width=348></TD><TD width=24></TD><TD width=252></TD></TR>
<TR><TD valign=top width=348><P style="line-height:13pt; margin:0px; padding-right:1.067px; font-size:11pt">Date: July 25, 2014</P>
</TD><TD valign=top width=276 colspan=2><P style="line-height:13pt; margin:0px; padding-right:2.4px; font-size:11pt">BIOCUBE, INC.</P>
</TD></TR>
<TR><TD valign=top width=348><P>&nbsp;</P></TD><TD valign=top width=276 colspan=2><P>&nbsp;</P></TD></TR>
<TR><TD valign=top width=348><P>&nbsp;</P></TD><TD valign=top width=276 colspan=2><P>&nbsp;</P></TD></TR>
<TR><TD valign=top width=348><P style="margin:0px; padding-right:1.067px; font-size:11pt">&nbsp;</P>
</TD><TD valign=top width=276 colspan=2><P style="margin:0px; padding-right:2.4px; font-size:11pt">&nbsp;</P>
</TD></TR>
<TR><TD valign=top width=348><P style="margin:0px; padding-right:1.067px; font-size:11pt">&nbsp;</P>
</TD><TD valign=top width=24><P style="line-height:13pt; margin:0px; padding-right:1.067px; font-size:11pt">By:</P>
</TD><TD style="border-bottom:1.333px solid #000000" valign=top width=252><P style="line-height:13pt; margin:0px; padding-right:1.067px; font-size:11pt">/s/ &nbsp;Boris Rubizhevsky</P>
</TD></TR>
<TR><TD valign=top width=348><P style="margin:0px; padding-right:1.067px; font-size:11pt">&nbsp;</P>
</TD><TD valign=top width=24><P style="margin:0px; padding-right:1.067px; font-size:11pt">&nbsp;</P>
</TD><TD valign=top width=252><P style="line-height:13pt; margin:0px; padding-right:1.067px; font-size:11pt">Name: Boris Rubizhevsky</P>
</TD></TR>
<TR><TD valign=top width=348><P style="margin:0px; padding-right:1.067px; font-size:11pt">&nbsp;</P>
</TD><TD valign=top width=24><P style="margin:0px; padding-right:1.067px; font-size:11pt">&nbsp;</P>
</TD><TD valign=top width=252><P style="line-height:13pt; margin:0px; padding-right:1.067px; font-size:11pt">Title: &nbsp;Chief Executive and Financial Officer</P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR>
<BR></P>
<P style="line-height:13pt; margin:0px; text-indent:310.333px; font-family:Calibri; font-size:11pt">3</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
</DIV></BODY>
<!-- EDGAR Validation Code: 089CB2AB -->
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "form8kbiocubejul252014.htm", "secsgml_size_bytes": 13273}]
{"company-data": {"conformed-name": "BioCube, INC.", "cik": "0001374135", "assigned-sic": "4522", "irs-number": "203547389", "state-of-incorporation": "DE", "fiscal-year-end": "0131"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-35227", "film-number": "14994637"}, "business-address": {"street1": "10 BLACKLEDGE COURT", "city": "CLOSTER", "state": "NJ", "zip": "07624", "phone": "201-750-2001"}, "mail-address": {"street1": "10 BLACKLEDGE COURT", "city": "CLOSTER", "state": "NJ", "zip": "07624"}, "former-company": [{"former-conformed-name": "ALLIANCE NETWORK COMMUNICATIONS HOLDINGS, INC.", "date-changed": "20090827"}, {"former-conformed-name": "Halcyon Jets Holdings, Inc.", "date-changed": "20070823"}, {"former-conformed-name": "GREENLEAF FOREST PRODUCTS, INC.", "date-changed": "20060829"}]}
Converted by EDGARwiz
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities and Exchange Act of 1934
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of Nearest event reported): July 22, 2014
BIOCUBE, INC.
(Exact Name of Registrant as Specified in its Charter)
Delaware
333-137920
20-3547389
(State of Organization)
(Commission File Number)
(I.R.S. Employer
Identification No.)
10 BLACKLEDGE COURT, CLOSTER NJ 07624
________________________________________________
(Address of principal executive offices)
Registrant's telephone number, including area code:  (201)750-2001
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨
Soliciting material pursuant to Rule 14a-12 under the Merger Act (17 CFR 240.14a -12)
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Merger Act (17 CFR 240.14d -2(b))
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Merger Act (17 CFR 240.13e -4(c))
ITEM 4.01.  CHANGES IN REGISTRANT'S CERTIFYING ACCOUNTANT.
(a) Dismissal of Independent Registered Public Accounting Firm
On July 22, 2014, Moss, Krusick & Associates, LLC ("
Moss
") was dismissed as the independent registered public accounting firm of BioCube, Inc. (the "
Company
").  The Company's Board of Directors, acting in the capacity of an audit committee, approved the dismissal of Moss.
Moss's reports on the Company's financial statements for the years ended January 31, 2013 and 2012, respectively, did not contain any adverse opinion or disclaimer of opinion, nor were they qualified or modified as to uncertainty, audit scope or accounting p
rinciples except that the reports for both years indicated that the Company is in the development stage and has suffered operating losses.  Accordingly, such reports indicated that there was substantial doubt as to the Company's ability to continue as a going concern and that the financial statements did not include any adjustments that might result from the outcome of this uncertainty.
During the years ended January 31, 2013 and 2012, and through July 22, 2014, there were no disagreements with Moss on any matter of accounting principles or practices, financial statement disclosure or auditing scope or procedure, which disagreements, if not resolved to the satisfaction of Moss, would have caused it to make reference thereto in connection with its reports on the financial statements for such years.  During the years ended January 31, 2013 and 2012, and through July 22, 2014, there were no matters that were either the subject of a disagreement as defined in Item 304(a)(1)(iv) of Regulation S-K or a reportable event as described in Item 304(a)(1)(v) of Regulation S-K.
The Company provided Moss with a copy of the foregoing disclosures and requested Moss to furnish the Company with a letter addressed to the Securities and Exchange Commission stating whether or not Moss agrees with the disclosures.  A copy of Moss's letter is filed as Exhibit 16.1 to this Current Report on Form 8-K.
(b) New Independent Registered Public Accounting Firm
On July 23, 2014, the Company's Board of Directors, acting in the capacity of an audit committee, engaged Li and Company, PC ("Li") as the Company's new independent registered public accounting firm to act as the principal accountant to audit the Company's financial statements.  During the Company's fiscal years ended January 31, 2013 and 2012, and through July 23, 2014, neither the Company, nor anyone acting on its behalf, consulted with Li regarding the application of accounting principles to a specific completed or proposed transaction or the type of audit opinion that might be rendered on the Company's financial statements, and no written report or oral advice was provided that Li concluded was an important factor considered by the Company in reaching a decision as to any such accounting, auditing or financial reporting issue.
Item 9.01.  Financial Statements and Exhibits.
Exhibit No.
Description
16.1
Letter to the Securities and Exchange Commission from Moss, Krusick & Associates, LLC regarding the matters disclosed in Item 4.01 of this Current Report on Form 8-K.
2
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: July 25, 2014
BIOCUBE, INC.
By:
/s/  Boris Rubizhevsky
Name: Boris Rubizhevsky
Title:  Chief Executive and Financial Officer
3